This site uses cookies. Some of these cookies are essential to the operation of the site, while others help to improve your experience by providing insights into how the site is being used. For more information, please see the ProZ.com privacy policy.
Cookie settings
Asked
Open questions
Answered
Asked | Open questions | Answered
Date Pair Term Level Status Answers (undeclined) Gloss
Dec 5 '21 eng>rus Persistent EGV Notification pro closed 3 ok
Dec 5 '21 eng>rus never double up doses or stack insulin pro closed 1 ok
Dec 5 '21 eng>rus Transmitter AB Time pro closed 2 no
Dec 5 '21 eng>rus Trend Graph Height pro closed 1 no
Dec 2 '21 eng>rus A HEALTHIER WORLD. DELIVERED. pro closed 6 ok
Dec 2 '21 eng>rus click I understand, show next screen pro closed 4 no
Dec 1 '21 eng>rus Pooled Completed Phase II studies pro closed 1 no
Nov 30 '21 eng>rus Requested Deposit Message pro closed 1 no
Nov 28 '21 eng>rus bladder length of the cuff pro closed 1 no
Nov 28 '21 eng>rus THE TAX ID vs INN pro closed 1 no
Nov 26 '21 eng>rus integral pouch pro closed 2 no
Nov 25 '21 eng>rus to obtain from the sponsor restriction of processing pro closed 2 no
Nov 25 '21 eng>rus non-government third party coverage pro closed 2 ok
Nov 25 '21 eng>rus and unknown at this time pro closed 2 no
Nov 24 '21 eng>rus Print/Digital pro closed 2 no
Nov 24 '21 eng>rus Cinch Bag pro closed 2 no
Nov 22 '21 eng>rus Iron, bone, blood cell production biomarkers pro closed 2 no
Nov 22 '21 eng>rus paratrabecular apposition of new bone pro closed 1 no
Nov 22 '21 eng>rus Extensive interconnecting meshwork of new bone pro closed 1 no
Nov 22 '21 eng>rus Dose Elimination Boundaries pro closed 2 no
Nov 22 '21 eng>rus iron staining pro closed 1 no
Nov 19 '21 eng>rus feed-forward effect pro closed 2 no
Nov 18 '21 eng>rus Immunomodulator imide drugs pro closed 2 no
Nov 11 '21 eng>rus SUBSCRIBER BROWNPROVIDER BROWN pro closed 2 ok
Nov 11 '21 eng>rus was Protein negative unknown pro closed 1 no
Nov 5 '21 eng>rus [x1] x [x2] ml plastic bags pro closed 1 no
Nov 3 '21 eng>rus ‘nonproportional Hazards’ package pro closed 1 no
Nov 3 '21 eng>rus Crossover Day 1 of every cycle pro closed 2 no
Nov 3 '21 eng>rus • Added pregnancy frequency pro closed 1 no
Nov 2 '21 eng>rus Subsequent Progression Status per Investigator pro closed 1 no
Nov 2 '21 eng>rus cross over patients pro closed 1 no
Nov 1 '21 eng>rus Single-dose, Sequential Dose Group Study pro closed 2 no
Oct 21 '21 eng>rus hospital consultant pro closed 1 no
Oct 21 '21 eng>rus further the clinical or business needs pro closed 1 ok
Oct 21 '21 eng>rus Samples may be kept and stored pro closed 3 no
Oct 21 '21 eng>rus the Travel Vendor pro closed 2 no
Oct 19 '21 eng>rus on the skin pro closed 2 no
Oct 17 '21 eng>rus rotate the areas pro closed 1 no
Oct 17 '21 eng>rus Master Global Biospecimen for Pharmacogenomic ICF pro closed 1 no
Oct 17 '21 eng>rus DNA research testing pro closed 1 ok
Oct 15 '21 eng>rus independent ethic and scientific review committee pro closed 3 no
Oct 13 '21 eng>rus non-ocular haemorrhages pro closed 2 no
Oct 12 '21 eng>rus systemic or ocular pro closed 2 no
Oct 11 '21 eng>rus depression of lateral condyle pro closed 3 no
Oct 11 '21 eng>rus standard errors are aggregated across the imputed datasets pro closed 2 no
Oct 11 '21 eng>rus Gross external examinations pro closed 3 no
Oct 11 '21 eng>rus Leakage from CNV pro closed 1 no
Oct 10 '21 eng>rus against all VEGF isoforms of VEGF-A pro closed 1 ok
Oct 10 '21 eng>rus Mean change in BCVA vs Mean average BCVA change pro closed 1 no
Oct 10 '21 eng>rus vitreal cell infiltration and floaters pro closed 1 no
Asked | Open questions | Answered